Immune Regulation


Immune Regulation is a clinical stage biotech company, pioneering new technologies for resetting the immune system, developing first-in-class therapies for inflammatory and immunological diseases. Our visionary approach aims to transform patients’ lives for the better.

Immune Regulation is at the leading edge in the field of developing novel immuno modulatory platforms to address unmet clinical needs, initially in the significant respiratory and rheumatoid arthritis markets as well as broader potential in other disease indications.

Working with innovative researchers and strategic partners to systematically identify, validate and develop therapeutic candidates, Immune Regulation: resetting expectations.

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.